Publications

These guidelines contain the general, initial and ongoing eligibility requirements to access certain medications for Fabry disease under the Life Saving Drugs Program.

Treating physicians use this application form to apply for a patient to access LSDP medication for Fabry disease for the first time, or after a break.

This report describes the findings from the HealthConsult review of the Stoma Appliance Scheme Schedule.

A Quarterly Financial Reporting non-uploadable template for aged care providers to use as a guide when collating their financial information.

Quarterly Financial Report data definitions for aged care providers to refer to when completing their QFR submissions each quarter.

The Data Governance Framework covers data we collected and data obtained from external sources, including other government organisations. It offers best-practice principles-based guidance on managing data and information assets throughout their lifecycle.

This infographic shows the number of flu (influenza) vaccinations reported to the Australian Immunisation Register (AIR) during 2021–2024, since 1 March.

Read the application guide for more information on completing your application.

Treating physicians use this form to reapply each year for a patient to receive ongoing LSDP medication for Fabry disease.

This document details frequently asked questions regarding 60-day dispensing.

An overview of how 60-day prescriptions will work in Residential Aged Care Homes (RACH), their supplying pharmacies and residents.

This report outlines the evaluation of evidence on the clinical effectiveness of western herbal medicine as part of the Natural Therapies Review 2024.

This kit updated in November 2024 provides information to prescribers about changes to Pharmaceutical Benefits Scheme (PBS) medicines available with 60-day dispensing quantities.

This updated January 2025 kit provides information for patients about 60-day prescriptions.

This procedure helps Aboriginal and Torres Strait Islander women understand how to take their own vaginal sample for a Cervical Screening Test.

Our Corporate Plan outlines how we will deliver the health system for all Australians throughout 2024–25.

The First Nations Health Funding Transition Advisory Group met on 12 July 2024. This document provides a record of the meeting.

This fact sheet details the new legislated Additional Community Supply Support (ACSS) payment under the Eighth Pharmacy Agreement (8CPA).

This weekly report provides a snapshot of data on the impact of COVID-19 in residential aged care facilities nationally. The report includes data on the number of services impacted and number of staff and resident cases, as well as workforce, testing and PPE provided to affected services.

These are the presentation slides for the Monthly Care Statements implementation webinar held on 29 August 2024

When someone decides to quit smoking or vaping, they’re more likely to succeed with the support of their family and friends.

Australian Technical Advisory Group on Immunisation (ATAGI) statement about the transition from quadrivalent to trivalent seasonal influenza vaccines in Australia.

This communique summarises the discussions and decisions by the First Nations General Practice Training Committee (FNGPTC) at its 21 June 2024 meeting.

This document includes the food categories and reformulation targets that make up the Partnership Reformulation Program and what products in each category are included or not.

This communique provides an update on the National Clinical Quality Registry Program in August 2024. It covers upcoming funding opportunities and other news and events.